Overview

Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist

Status:
Terminated
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators would like to see if giving medroxyprogesterone acetate for 3 weeks after Leuprolide acetate injection will help to decrease this amount of bleeding, decrease the amount of nausea, bloating and cramping and increase patient satisfaction
Phase:
Phase 4
Details
Lead Sponsor:
Kaiser Permanente
Treatments:
Leuprolide
Medroxyprogesterone
Medroxyprogesterone Acetate